Grant Holder |
Completed project Institute Amount Awarded Duration Type of Award |
Title
Involvement of the PPARs in the development and treatment of breast cancer
Synopsis
Little is known about peroxisome proliferator-activated receptors (PPARs), a group of molecules thought to be involved in the growth of breast tumours. Dr Gill hopes to expose these molecules as future targets for breast cancer drugs
Aims & Goals
"The funding will allow the potential of the new drugs, developed in Newcastle, for the therapy of hormone-resistant breast cancer".
Publications
| Title | GW9662, a potent antagonist of PPARgamma , inhibits growth of breast tumour cells and promotes the anticancer effects pf the PPARgamma agonist rosiglitazone, independently of PPARgamma activation |
| Year | 2004 |
| Authors | Seargent, J.M, Yates E.A and Gill, J.H |
©2008 Breast Cancer Campaign. All rights reserved.
Breast Cancer Campaign is a charity registered by the Charity Commission for England and Wales (no. 299758) and a company limited by guarantee registered in England (no 05074725) whose registered office is at Clifton Centre, 110 Clifton Street, London EC2A 4HT.